Anti-Moesin antibody [MSN/492] - BSA and Azide free (ab215840)
Key features and details
- Mouse monoclonal [MSN/492] to Moesin - BSA and Azide free
- Suitable for: ICC, WB, IHC-P
- Knockout validated
- Reacts with: Human
- Isotype: IgG1
Overview
-
Product name
Anti-Moesin antibody [MSN/492] - BSA and Azide free
See all Moesin primary antibodies -
Description
Mouse monoclonal [MSN/492] to Moesin - BSA and Azide free -
Host species
Mouse -
Tested applications
Suitable for: ICC, WB, IHC-Pmore details -
Species reactivity
Reacts with: Human
Does not react with: Rat -
Immunogen
Recombinant full length protein corresponding to Human Moesin aa 1 to the C-terminus.
Database link: P26038 -
Positive control
- IHC-P: Human melanoma, testicular carcinoma and placenta tissues. WB: HeLa whole cell lysate
-
General notes
The Life Science industry has been in the grips of a reproducibility crisis for a number of years. Abcam is leading the way in addressing this with our range of recombinant monoclonal antibodies and knockout edited cell lines for gold-standard validation. Please check that this product meets your needs before purchasing.
If you have any questions, special requirements or concerns, please send us an inquiry and/or contact our Support team ahead of purchase. Recommended alternatives for this product can be found below, along with publications, customer reviews and Q&As
Properties
-
Form
Liquid -
Storage instructions
Shipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C long term. Avoid freeze / thaw cycle. -
Storage buffer
pH: 7.2
Constituent: 100% PBS -
Carrier free
Yes -
Concentration information loading...
-
Purity
Protein A/G purified -
Purification notes
ab215840 is purified from Bioreactor Concentrate by Protein A/G. -
Clonality
Monoclonal -
Clone number
MSN/492 -
Isotype
IgG1 -
Light chain type
kappa -
Research areas
Associated products
-
Alternative Versions
-
Compatible Secondaries
-
Conjugation kits
-
Isotype control
Applications
The Abpromise guarantee
Our Abpromise guarantee covers the use of ab215840 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
Application | Abreviews | Notes |
---|---|---|
ICC |
Use a concentration of 1 - 2 µg/ml.
|
|
WB |
Use a concentration of 1 - 2 µg/ml. Predicted molecular weight: 68 kDa.
|
|
IHC-P |
Use a concentration of 0.5 - 1 µg/ml. Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
|
Notes |
---|
ICC
Use a concentration of 1 - 2 µg/ml. |
WB
Use a concentration of 1 - 2 µg/ml. Predicted molecular weight: 68 kDa. |
IHC-P
Use a concentration of 0.5 - 1 µg/ml. Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol. |
Target
-
Function
Probably involved in connections of major cytoskeletal structures to the plasma membrane. -
Tissue specificity
In all tissues and cultured cells studied. -
Sequence similarities
Contains 1 FERM domain. -
Post-translational
modificationsPhosphorylation on Thr-558 is crucial for the formation of microvilli-like structures. -
Cellular localization
Cell membrane. Cytoplasm > cytoskeleton. Apical cell membrane. Cell projection > microvillus membrane. Phosphorylated form is enriched in microvilli-like structures at apical membrane (By similarity). Increased cell membrane localization of both phosphorylated and non-phosphorylated forms seen after thrombin treatment. - Information by UniProt
-
Database links
- Entrez Gene: 4478 Human
- Omim: 309845 Human
- SwissProt: P26038 Human
- Unigene: 87752 Human
-
Alternative names
- Epididymis luminal protein 70 antibody
- HEL70 antibody
- Membrane organizing extension spike protein antibody
see all
Images
-
This data was developed using ab216033, the same antibody clone in a different buffer formulation.
Immunocytochemistry analysis of paraformaldehyde-fixed HeLa (human epithelial cell line from cervix adenocarcinoma) cells labeling Moesin with ab216033 followed by goat anti-Mouse IgG-CF488 (Green). The nuclear counterstain is Reddot (Red).
-
All lanes : Anti-Moesin antibody [MSN/492] (ab216033) at 1/1000 dilution
Lane 1 : Wild-type HeLa cell lysate
Lane 2 : MSN knockout HeLa cell lysate
Lysates/proteins at 20 µg per lane.
Performed under reducing conditions.
Predicted band size: 68 kDa
Observed band size: 75 kDa why is the actual band size different from the predicted?False colour image of Western blot: Anti-Moesin antibody [MSN/492] staining at 1/1000 dilution, shown in green; Rabbit Anti-GAPDH antibody [EPR16891] (ab181602) loading control staining at 1/20000 dilution, shown in red. In Western blot, ab216033 was shown to bind specifically to Moesin. A band was observed at 75 kDa in wild-type HeLa cell lysates with no signal observed at this size in MSN knockout cell line ab265020 (knockout cell lysate ab257542). To generate this image, wild-type and MSN knockout HeLa cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Mouse IgG H&L (IRDye® 800CW) preabsorbed (ab216772) and Goat anti-Rabbit IgG H&L (IRDye® 680RD) preabsorbed (ab216777) at 1/20000 dilution.
-
Immunohistochemical analysis of formalin-fixed, paraffin-embedded Human placenta tissue labeling Moesin with ab215840 at 1 μg/ml dilution.
-
Immunohistochemical analysis of formalin-fixed, paraffin-embedded Human testicular carcinoma tissue labeling Moesin with ab215840 at 1 μg/ml dilution.
-
Immunohistochemical analysis of formalin-fixed, paraffin-embedded Human melanoma tissue labeling Moesin with ab215840 at 1 μg/ml dilution.
Datasheets and documents
-
Datasheet download
References (0)
ab215840 has not yet been referenced specifically in any publications.